Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
Merck Sharp & Dohme LLC
Javed Butler; Ciaran J McMullan; Kevin J Anstrom; Irina Barash; Marc P Bonaca; Maria Borentain; Stefano Corda; Justin A Ezekowitz; G Michael Felker; Davis Gates; Carolyn S P Lam; Eldrin F Lewis; JoAnn Lindenfeld; Robert J Mentz; Christopher M O'Connor; Piotr Ponikowski; Yogesh N V Reddy; Giuseppe M C Rosano; Clara Saldarriaga; Michele Senni; Lilin She; Pedro Pinto Teixeira; James Udelson; Alessia Urbinati; Vanja Vlajnic; Adriaan A Voors; Aiwen Xing; Mahesh J Patel; Faiez Zannad; VICTOR Study Group